AbbVie (ABBV) Prepaid Assets (2012 - 2026)
AbbVie's (ABBV) quarterly Prepaid Assets came in at $8.1 billion in Q2 2026, up 56.8% year-over-year from $5.2 billion in Q2 2025, and up 23.28% quarter-over-quarter from $6.6 billion in Q1 2026.
Analysis
AbbVie (ABBV) Prepaid Assets (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Prepaid Assets for 15 consecutive years, with $8.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 56.8% year-over-year to $8.1 billion in Q2 2026; TTM through Jun 2026 was $8.1 billion, a 56.8% increase from a year earlier, with the FY2025 full-year figure at $6.3 billion, up 27.72% from the prior year.
- Prepaid Assets was $8.1 billion for Q2 2026 at AbbVie, up from $6.6 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $8.1 billion in Q2 2026 and troughed at $4.4 billion in Q4 2022.
- A 5-year average of $5.1 billion and a median of $4.7 billion in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slipped 11.86% in 2022 and jumped 56.8% in 2026, its largest moves.
- Over 5 years, Prepaid Assets stood at $4.4 billion in 2022, then rose by 12.07% to $4.9 billion in 2023, then dropped by 0.1% to $4.9 billion in 2024, then gained by 27.72% to $6.3 billion in 2025, then climbed by 29.49% to $8.1 billion in 2026.
- The last three Prepaid Assets figures came in at $8.1 billion (Q2 2026), $6.6 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.15 Bn |
| Mar 31, 2026 | 6.61 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 5.16 Bn |
| Jun 30, 2025 | 5.20 Bn |
| Mar 31, 2025 | 5.50 Bn |
| Dec 31, 2024 | 4.93 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.72 Bn |
| Mar 31, 2024 | 4.61 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 4.54 Bn |
| Jun 30, 2023 | 4.54 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.51 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 4.33 Bn |